Espinoza Octavio bought LGND
August 12, 2026 · Form 4 insider transaction
Espinoza Octavio bought 7,171 shares of Ligand Pharmaceuticals Incorporated at $57.22 per share, a transaction worth $410.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,171
Price
$57.22
Total value
$410.3K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after55,989
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 13, 2026, in accordance with Rule 10b5-1.